Gensight Biologics SA Stock
Your prediction
Gensight Biologics SA Stock
Gensight Biologics SA gained 2.140% today.
Our community identified positive and negative aspects for Gensight Biologics SA stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the Gensight Biologics SA stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Gensight Biologics SA in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
G***** c******* t* c**********
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Gensight Biologics SA vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Gensight Biologics SA | 2.140% | -4.191% | -2.604% | -64.449% | -27.425% | -96.564% | -98.890% |
| India Globalization Capital | 0.000% | 6.957% | -0.806% | 6.034% | 3.361% | -8.209% | -81.614% |
| Protara Therapeutics Inc. | -0.280% | -2.983% | -6.460% | 18.101% | -5.202% | 56.593% | -69.800% |
| Neurosearch As Nam. | 0.000% | 8.333% | 11.765% | -24.000% | -1.789% | -54.679% | -20.706% |
